Maccioni Paola, Kaczanowska Katarzyna, Lobina Carla, Regonini Somenzi Laura, Bassareo Valentina, Gessa Gian Luigi, Lawrence Harshani R, McDonald Patricia, Colombo Giancarlo
Neuroscience Institute, Section of Cagliari, National Research Council of Italy, Monserrato (CA), Italy.
Department of Chemistry, Scripps Research, La Jolla, California, United States.
Alcohol. 2023 Nov;112:61-70. doi: 10.1016/j.alcohol.2023.07.004. Epub 2023 Jul 24.
Recent studies have demonstrated the ability of the positive allosteric modulator (PAM) of the GABA receptor (GABA PAM), KK-92A, to suppress operant alcohol self-administration and reinstatement of alcohol seeking in selectively bred Sardinian alcohol-preferring (sP) rats. The present study was designed to scrutinize the suppressing effects of KK-92A on alcohol-related behaviors; to this end, four separate experiments were conducted to address just as many new research questions, some of which bear translational value. Experiment 1 found that 7-day treatment with KK-92A (0, 5, 10, and 20 mg/kg, intraperitoneally [i.p.]) effectively reduced alcohol intake in male sP rats exposed to the home-cage 2-bottle "alcohol (10% v/v) vs. water" choice regimen with 1 hour/day limited access, extending to excessive alcohol drinking the ability of KK-92A to suppress operant alcohol self-administration. Experiment 2 demonstrated that the ability of KK-92A to reduce lever-responding for alcohol was maintained also after acute, intragastric treatment (0, 20, and 40 mg/kg) in female sP rats trained to lever-respond for 15% (v/v) alcohol under the fixed ratio 5 schedule of reinforcement. In Experiment 3, acutely administered KK-92A (0, 5, 10, and 20 mg/kg, i.p.) dampened alcohol-seeking behavior in female sP rats exposed to a single session under the extinction responding schedule. Experiment 4 used a taste reactivity test to demonstrate that acute treatment with KK-92A (0 and 20 mg/kg, i.p.) did not alter either hedonic or aversive reactions to a 15% (v/v) alcohol solution in male sP rats, ruling out that KK-92A-induced reduction of alcohol drinking and self-administration could be due to alterations in alcohol palatability. Together, these results enhance the behavioral pharmacological profile of KK-92A and further strengthen the notion that GABA PAMs may represent a novel class of ligands with therapeutic potential for treating alcohol use disorder.
最近的研究表明,γ-氨基丁酸受体正变构调节剂(GABA PAM)KK-92A能够抑制选择性培育的撒丁岛嗜酒(sP)大鼠的操作性酒精自我给药及酒精觅求行为的恢复。本研究旨在仔细研究KK-92A对酒精相关行为的抑制作用;为此,进行了四项独立实验以解决同样多的新研究问题,其中一些具有转化价值。实验1发现,用KK-92A(0、5、10和20mg/kg,腹腔注射[i.p.])进行7天治疗,可有效降低暴露于笼内两瓶“酒精(10% v/v)对水”选择方案且每天限时1小时的雄性sP大鼠的酒精摄入量,将KK-92A抑制操作性酒精自我给药的能力扩展至过量饮酒情况。实验2表明 在接受固定比例5强化程序训练以按压杠杆获取15%(v/v)酒精的雌性sP大鼠中,急性灌胃给药(0、20和40mg/kg)后KK-92A降低对酒精杠杆反应的能力也得以维持。在实验3中,急性给予KK-92A(0、5、10和20mg/kg,腹腔注射)可减弱暴露于消退反应程序下单次实验的雌性sP大鼠的酒精觅求行为。实验4采用味觉反应测试表明,急性给予KK-92A(0和20mg/kg,腹腔注射)不会改变雄性sP大鼠对15%(v/v)酒精溶液的享乐或厌恶反应,排除了KK-92A导致酒精摄入量和自我给药减少可能是由于酒精适口性改变的可能性。总之,这些结果完善了KK-92A的行为药理学特征,并进一步强化了GABA PAMs可能代表一类具有治疗酒精使用障碍潜力的新型配体的观点。